Among the physiopathological entities that comprise MS, the serum level of insulin-like growth factor I (IGF-I) seems to be the one that is most closely linked with PCa.7 The hyperinsulinemia observed in patients with MS is the factor responsible for stimulating the production of IGF-I in the liver. This evidence concerns the gene IGF1 and posterior cortical atrophy.